Concurrent chemoradiation using cisplatinum, vinorelbine, and radical radiotherapy with 20 fractions in 4 weeks for patients with inoperable NSCLC and good performance status

被引：0
|
作者：
Maguire, J [1 ]
Smith, N [1 ]
Kelly, V [1 ]
Smyth, C [1 ]
Ledson, M [1 ]
Walshaw, M [1 ]
机构：
[1] Ctr Cardiothorac, Liverpool Lung Canc Unit, Liverpool, Merseyside, England
来源：
THORAX | 2004年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 31 条
  • [1] Accelerated hypofractionated radical radiotherapy concurrent with cisplatinum and vinorelbine for inoperable NSCLC
    Maguire, J
    Kelly, V
    Page, R
    Ledson, M
    Smyth, C
    Walshaw, M
    LUNG CANCER, 2005, 49 : S171 - S172
  • [2] Surgical resection after radical accelerated hypofractionated radiotherapy concurrent with cisplatinum/vinorelbine for initially inoperable NSCLC
    Maguire, J.
    Kelly, V.
    Page, R.
    Carr, M.
    Soorae, A.
    Gosney, J.
    LUNG CANCER, 2007, 57 : S3 - S3
  • [3] Pre-SOCCAR pilot study of concurrent chemoradiation using 55 Gy in 20 fractions with cisplatinum and vinorelbine in stage III NSCLC
    Maguire, J.
    Mohammed, N.
    Hicks, J.
    Appel, W.
    Skailes, G.
    McMenemin, R.
    Mulvenna, P.
    Peedell, C.
    Kelly, V.
    LUNG CANCER, 2012, 75 : S45 - S45
  • [4] Venous thromboembolism associated with enhanced survival for patients undergoing concurrent chemoradiation (55 Gy/20f/4w plus cisplatinum and vinorelbine) for inoperable NSCLC
    Jones, S.
    Kelly, V.
    Maguire, J.
    LUNG CANCER, 2015, 87 : S54 - S54
  • [5] Long term local tumour control in inoperable NSCLC treated with accelerated hypofractionated radiotherapy and concurrent cisplatinum and vinorelbine
    Kelly, V.
    Maguire, J.
    LUNG CANCER, 2016, 91 : S49 - S49
  • [6] SURGERY AFTER CONCURRENT CHEMORADIATION WITH 55 GY IN 20 FRACTIONS OVER FOUR WEEKS WITH FULL DOSE PLATINUM AND VINORELBINE
    Maguire, Joe
    Littler, John
    Kelly, Veronica
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S393 - S394
  • [7] An audit of use of concurrent chemo-radiotherapy with cisplatinum and vinorelbine with 55 GY in 20 fractions in seven UK treatment centres
    Kelly, V.
    Hicks, J.
    Mcmenemin, R.
    Skailes, G.
    Barnett, C.
    Simpson, S.
    Maguire, J.
    Maguire, J.
    THORAX, 2007, 62 : A69 - A69
  • [8] Chemotherapy and radical radiotherapy for patients with inoperable NSCLC aged 70 and over with inoperable NSCLC-results of a treatment policy based on stage performance status at presentation
    Maguire, J
    Kelly, V
    Smith, N
    Smyth, C
    Ledson, M
    Walshaw, M
    THORAX, 2003, 58 : 5 - 6
  • [9] Do We Have Better Choice for Inoperable Lung Cancer Patients with Good Performance Status? Concurrent Versus Sequential Chemo-Radiotherapy
    Wu, N.
    Li, X.
    Li, S.
    Yan, S.
    Wang, Y.
    Wang, X.
    Yang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1098 - S1099
  • [10] A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC)
    Liao, Z
    Komaki, R
    Milas, L
    Chen, Y
    Kies, M
    Chang, J
    Jeter, M
    Guerrero, T
    Blumenschein, G
    Cox, J
    LUNG CANCER, 2005, 49 : S372 - S372
1234